Alkermes (ALKS) EPS (Diluted) (2010 - 2026)
Powered by 
Analysis
Alkermes (ALKS) EPS (Diluted) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.84 Bn | 623.08 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 441.33 Bn | 434.76 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 364.84 Bn | 357.70 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 266.34 Bn | 258.65 Bn | 11.24 Bn | 1.67 |
| 5 | Pfizer | 159.07 Bn | 147.37 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 52.48 Bn | 45.10 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 44.22 Bn | 44.22 Bn | - | -3.06 |
| 8 | Incyte | 25.24 Bn | 20.70 Bn | 1.57 Bn | 2.81 |
| 9 | United Therapeutics | 21.42 Bn | 18.76 Bn | 683.80 Mn | 7.27 |
| 10 | Alkermes | 7.58 Bn | 6.92 Bn | 397.90 Mn | 0.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00 |
| Mar 31, 2026 | -0.40 |
| Dec 31, 2025 | 0.29 |
| Sep 30, 2025 | 0.49 |
| Jun 30, 2025 | 0.52 |
| Mar 31, 2025 | 0.13 |
| Dec 31, 2024 | 0.87 |
| Sep 30, 2024 | 0.55 |
| Jun 30, 2024 | 0.53 |
| Mar 31, 2024 | 0.21 |
| Dec 31, 2023 | 0.71 |
| Sep 30, 2023 | 0.27 |
| Jun 30, 2023 | 1.38 |
| Mar 31, 2023 | -0.29 |
| Dec 31, 2022 | 0.54 |
| Sep 30, 2022 | -0.39 |
| Jun 30, 2022 | -0.18 |
| Mar 31, 2022 | -0.22 |
| Dec 31, 2021 | 0.78 |
| Sep 30, 2021 | -0.18 |